FDA Says No Decision Reached Yet On Oxybenzone/Octinoxate Ban Petition
This article was originally published in The Rose Sheet
Executive Summary
According to industry, available scientific evidence regarding oxybenzone’s and octinoxate’s effects on coral does not support their removal from the OTC sunscreen drug monograph’s list of permitted UV filters, and FDA is fully compliant with federal environmental laws, contrary to the Center for Biological Diversity’s suggestions. FDA says the petition raises complex issues requiring extensive review.